ISIS

Ionis Pharmaceuticals, (ISIS)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ISIS
DataOraFonteTitoloSimboloCompagnia
06/01/201013:00PR Newswire (US)Isis Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ISIS
05/01/201014:00PR Newswire (US)Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001NASDAQ:ISIS
21/12/200914:15PR Newswire (US)Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to TevaNASDAQ:ISIS
23/11/200914:00PR Newswire (US)Isis Pharmaceuticals (Nasdaq: ISIS) Letter to ShareholdersNASDAQ:ISIS
20/10/200913:00PR Newswire (US)Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor ConferenceNASDAQ:ISIS
09/09/200913:00PR Newswire (US)Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged ConferenceNASDAQ:ISIS
06/08/200914:23Dow Jones NewsIsis 2Q Loss Narrows, Helped By Genzyme PartnershipNASDAQ:ISISIsis Pharmaceuticals Inc.
06/08/200913:00PR Newswire (US)Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009NASDAQ:ISIS
04/08/200913:00PR Newswire (US)Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth ConferenceNASDAQ:ISIS
20/05/200919:45Dow Jones NewsUPDATE: Genzyme, Isis Cholesterol Drug Data Raise QuestionsNASDAQ:ISISIsis Pharmaceuticals Inc.
20/05/200916:06Dow Jones NewsGenzyme, Isis Cholesterol Drug Meets Goal In Late StudyNASDAQ:ISISIsis Pharmaceuticals Inc.
07/05/200913:54Dow Jones NewsIsis Swings To 1Q Profit Amid Gain, Partnership RevenueNASDAQ:ISISIsis Pharmaceuticals Inc.
14/02/200614:00PR Newswire (US)OncoGenex Appoints New CFO and Board MemberNASDAQ:ISIS
16/08/200515:18PR Newswire (US)OncoGenex Announces Completion of $12.8 Million Venture FinancingNASDAQ:ISIS
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ISIS

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network